Published in Kardiol Pol on January 01, 2017
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J (2008) 12.31
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med (2014) 9.33
Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med (2005) 9.27
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J (2014) 6.32
Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol (2009) 5.31
Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med (2013) 4.98
Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol (2004) 3.63
Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J (2004) 3.51
The influence of acute pulmonary embolism on early and delayed prognosis for patients with chronic heart failure. Cardiol J (2012) 3.19
Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial. Circulation (2013) 2.82
Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest (2006) 2.43
Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism. Chest (2003) 2.40
Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat (2006) 2.30
Fractional diastolic and systolic pressure in the ascending aorta are related to the extent of coronary artery disease. Am J Hypertens (2004) 2.21
Should a cardioverter-defibrillator be implanted in an Andersen-Tawil syndrome patient with severe ventricular arrhythmias and syncope? Kardiol Pol (2014) 1.99
Correlation between clinical parameters of periodontal disease and mean platelet volume in patients with coronary artery disease: a pilot study. Kardiol Pol (2013) 1.98
Acute pulmonary embolism treatment with rivaroxaban results in a shorter duration of hospitalisation compared to standard therapy: an academic centre experience. Kardiol Pol (2016) 1.95
Management of grown up congenital heart disease. Eur Heart J (2003) 1.94
Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation (2011) 1.92
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol (2009) 1.78
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol (2002) 1.77
Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med (2002) 1.72
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol (2008) 1.69
Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation (2011) 1.68
Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. Chest (2007) 1.66
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. Eur Respir J (2012) 1.63
Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol (2003) 1.62
Is it possible to use standard electrocardiography for risk assessment of patients with pulmonary embolism? Kardiol Pol (2009) 1.61
2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. Rev Esp Cardiol (Engl Ed) (2016) 1.61
Emerging markers of atherosclerosis before and after bariatric surgery. Obes Surg (2015) 1.55
Predictors of the atrial fibrillation occurrence in patients with Wolff-Parkinson-White syndrome. Kardiol Pol (2009) 1.51
Neutrophil gelatinase-associated lipocalin, cystatin C and eGFR indicate acute kidney injury and predict prognosis of patients with acute pulmonary embolism. Heart (2012) 1.50
Usefulness of echocardiography in the identification of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis. Kardiol Pol (2011) 1.47
Acute pulmonary embolism: analysis of consecutive 353 patients hospitalised in a single centre. A 3-year experience. Kardiol Pol (2012) 1.44
Endothelin is not elevated in acute pulmonary embolism. Thromb Res (2009) 1.39
[Transient QT-interval prolongation and T wave inversion: diagnostic difficulties]. Kardiol Pol (2013) 1.39
'Syringe-in-the-pocket'--a new approach to the outpatient thromboembolic prophylaxis of recurrent atrial fibrillation. Cardiology (2007) 1.39
The prognostic role of exercise echocardiography in heart failure. Kardiol Pol (2011) 1.39
Causes of hospitalization and prognosis in patients with cardiovascular diseases. Secular trends in the years 2006-2014 according to the SILesian CARDiovascular (SILCARD) database. Pol Arch Med Wewn (2016) 1.38
Obesity and antiplatelet effects of acetylsalicylic acid and clopidogrel in patients with stable angina pectoris after percutaneous coronary intervention. Pol Arch Med Wewn (2015) 1.38
End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. J Am Coll Cardiol (2004) 1.24
Thromboembolic complications in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Europace (2006) 1.19
Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J (2005) 1.12
Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension. Eur Respir J (2012) 1.11
Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pulmonary embolism. Am J Cardiol (2002) 1.06
Biodegradation and surfactant-mediated biodegradation of diesel fuel by 218 microbial consortia are not correlated to cell surface hydrophobicity. Appl Microbiol Biotechnol (2009) 1.05
Biventricular noncompaction associated with left ventricular systolic and diastolic dysfunction and severe pulmonary hypertension in a young man. Circ J (2009) 1.03
Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation (2003) 1.02
Genetic association of the serotonin transporter in pulmonary arterial hypertension. Am J Respir Crit Care Med (2006) 1.01
Usefulness of the evaluation of left ventricular diastolic function changes during stress echocardiography in predicting exercise capacity in patients with ischemic heart failure. J Am Soc Echocardiogr (2008) 1.00
Pulmonary artery dilatation correlates with the risk of unexpected death in chronic arterial or thromboembolic pulmonary hypertension. Chest (2012) 0.98
Mean platelet volume predicts early death in acute pulmonary embolism. Heart (2009) 0.93
Cancer Screening in Unprovoked Venous Thromboembolism. N Engl J Med (2015) 0.92
Characteristics and prognosis of patients with decompensated right ventricular failure during the course of pulmonary hypertension. Kardiol Pol (2008) 0.91
Multidetector CT scan for acute pulmonary embolism: embolic burden and clinical outcome. Chest (2012) 0.91
Effectiveness of intrapericardial administration of streptokinase in purulent pericarditis. Herz (2004) 0.90
Biodegradation of diesel/biodiesel blends by a consortium of hydrocarbon degraders: effect of the type of blend and the addition of biosurfactants. Bioresour Technol (2008) 0.90
Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test. Eur Heart J (2011) 0.89
Cardiac magnetic resonance in pulmonary arterial hypertension: a step in the right direction. Eur Heart J (2007) 0.89
Persistent NT-proBNP elevation in acute pulmonary embolism predicts early death. Clin Chim Acta (2007) 0.88
Familial chronic thromboembolic pulmonary hypertension in a mother and a son: successful treatment with refined balloon pulmonary angioplasty. Pol Arch Med Wewn (2016) 0.87
Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality. Nephrol Dial Transplant (2007) 0.87
Alteration of myocardial sarcoplasmic reticulum Ca2+-ATPase and Na+-Ca2+ exchanger expression in human left ventricular volume overload. Eur J Heart Fail (2007) 0.87
Renal artery stenosis in patients with coronary artery disease. Kardiol Pol (2008) 0.87
[Guidelines on the diagnosis and management of acute pulmonary embolism]. G Ital Cardiol (Rome) (2009) 0.87
Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study. Kardiol Pol (2003) 0.87
Utilization of Triton X-100 and polyethylene glycols during surfactant-mediated biodegradation of diesel fuel. J Hazard Mater (2011) 0.86
Relative quantitative PCR to assess bacterial community dynamics during biodegradation of diesel and biodiesel fuels under various aeration conditions. Bioresour Technol (2010) 0.86
Heart rate turbulence assessment in systemic sclerosis: the role for the detection of cardiac autonomic nervous system dysfunction. Rheumatology (Oxford) (2009) 0.85
Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia. Med Sci Monit (2011) 0.85
Predictive value of RT-PCR PML-RARA transcript monitoring for extramedullary relapse of acute promyelocytic leukemia in the pleura, heart and pericardium after allogeneic SCT. Ann Transplant (2007) 0.85
Influence of calcium and vitamin D supplementation on weight and fat loss in obese women. Obes Facts (2008) 0.85
TIMI Risk Score accurately predicts risk of death in 30-day and one-year follow-up in STEMI patients treated with primary percutaneous coronary interventions. Kardiol Pol (2007) 0.84
Plasma neuropeptide Y immunoreactivity influences left ventricular mass in pheochromocytoma. Clin Chim Acta (2004) 0.84